ATE193551T1 - Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen - Google Patents

Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen

Info

Publication number
ATE193551T1
ATE193551T1 AT92909519T AT92909519T ATE193551T1 AT E193551 T1 ATE193551 T1 AT E193551T1 AT 92909519 T AT92909519 T AT 92909519T AT 92909519 T AT92909519 T AT 92909519T AT E193551 T1 ATE193551 T1 AT E193551T1
Authority
AT
Austria
Prior art keywords
inhibitors
compositions
oligosaccharides
methods
enzyme substrates
Prior art date
Application number
AT92909519T
Other languages
English (en)
Inventor
Chi-Huey Wong
Yoshitaka Ichikawa
Gwo-Jenn Shen
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/670,701 external-priority patent/US5278299A/en
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE193551T1 publication Critical patent/ATE193551T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92909519T 1991-03-18 1992-03-17 Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen ATE193551T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/670,701 US5278299A (en) 1991-03-18 1991-03-18 Method and composition for synthesizing sialylated glycosyl compounds
US70760091A 1991-05-30 1991-05-30
US73821191A 1991-07-30 1991-07-30
US85240992A 1992-03-16 1992-03-16
PCT/US1992/002178 WO1992016640A1 (en) 1991-03-18 1992-03-17 Oligosaccharide enzyme substrates and inhibitors: methods and compositions

Publications (1)

Publication Number Publication Date
ATE193551T1 true ATE193551T1 (de) 2000-06-15

Family

ID=27505341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909519T ATE193551T1 (de) 1991-03-18 1992-03-17 Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen

Country Status (8)

Country Link
US (3) US5759823A (de)
EP (1) EP0576592B1 (de)
JP (1) JP3476455B2 (de)
AT (1) ATE193551T1 (de)
AU (1) AU668505B2 (de)
CA (1) CA2106301C (de)
DE (1) DE69231127D1 (de)
WO (1) WO1992016640A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE193551T1 (de) 1991-03-18 2000-06-15 Scripps Research Inst Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
SK42594A3 (en) * 1991-10-15 1994-10-05 Scripps Research Inst Method of production of fucosylated carbohydrates
US5559103A (en) * 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
EP0671409A3 (de) * 1994-03-11 1996-06-12 Hoechst Ag Malonsäurederivate mit antiadhäsiven Eigenschaften.
IT1268954B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche
US6030815A (en) * 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5922577A (en) * 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5876980A (en) * 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
US5728554A (en) * 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
WO1997037682A1 (en) * 1996-04-10 1997-10-16 Cytel Corporation Nucleic acids encoding gdp-fucose pyrophosphorylase
ES2218806T3 (es) 1997-01-16 2004-11-16 Neose Technologies, Inc. Sialilacion practica in vitro de glicoproteinas recombinantes.
US5952203A (en) * 1997-04-11 1999-09-14 The University Of British Columbia Oligosaccharide synthesis using activated glycoside derivative, glycosyl transferase and catalytic amount of nucleotide phosphate
EP1903114A3 (de) 1997-12-01 2008-07-23 Neose Technologies, Inc. Enzymatische Synthese von Gangliosiden
ATE355295T1 (de) 1998-10-06 2006-03-15 Massachusetts Inst Technology Synthese von oligosacchariden, reagenzien und verfahren
US6699705B2 (en) 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
US6503744B1 (en) 1999-02-01 2003-01-07 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
JP2002537796A (ja) * 1999-03-02 2002-11-12 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒトグリコシル化酵素
US6949372B2 (en) 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6395559B1 (en) 1999-05-04 2002-05-28 Orchid Biosciences, Inc. Multiple fluid sample processor with single well addressability
EP1185269B1 (de) * 1999-05-24 2007-11-14 Abaron Biosciences, Inc. Glycosyltransferase inhibitoren
KR100349696B1 (ko) * 1999-06-30 2002-08-22 주식회사 하이닉스반도체 화학적 팽창 공정을 이용한 반도체 소자의 금속배선 형성을 위한 대머신 구조 형성방법
EP1189643A1 (de) * 1999-06-30 2002-03-27 Novartis AG Ophthalmischer formkörper
FI19992070A7 (fi) 1999-09-28 2001-03-29 Carbion Oy Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi
JP4599505B2 (ja) * 2000-03-03 2010-12-15 明治乳業株式会社 Ｎ−アセチル−β−ヘキソサミニド誘導体の製造方法
KR100446483B1 (ko) * 2000-03-31 2004-09-01 미시간 스테이트 유니버시티 옥심 또는 이민으로부터 1,5-디데옥시-1,5-이미노 헥시톨제조방법
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7863020B2 (en) * 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
EP2305312B1 (de) 2001-10-10 2015-03-04 ratiopharm GmbH Neumodulierung und Glykokonjugation von Follitropin (FSH)
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
AUPR879501A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6852485B1 (en) 2002-01-22 2005-02-08 California State University Fullerton Foundation Method for identifying a compound for the treatment of microorganism infections by inhibiting energy storage and utilization in pathogens
WO2004009838A2 (en) 2002-07-23 2004-01-29 Neose Technologies, Inc. H. Pylori FUCOSYLTRANSFERASES
EP1636248A4 (de) 2002-12-16 2006-09-06 Halozyme Inc Humanes chondroitinase-glycoprotein(chasegp), verfahren zu seiner herstellung und dieses enthaltendepharmazeutische zusammensetzungen
AU2004218354B2 (en) 2003-03-05 2009-10-01 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
EP1615945B1 (de) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylierungsverfahren und durch die verfahren hergestellte proteine/peptide
WO2006127896A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
EP1644390B1 (de) * 2003-06-24 2011-04-20 Isis Innovation Limited Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1718739B1 (de) 2004-02-04 2011-07-13 Novo Nordisk A/S Verfahren zur rückfaltung von säuger-glycosyltransferasen
US20050287639A1 (en) 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
EP1814573B1 (de) 2004-10-29 2016-03-09 ratiopharm GmbH Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
EP1871795A4 (de) 2005-04-08 2010-03-31 Biogenerix Ag Zusammensetzungen und verfahren zur herstellung von glycosylierungsmutanten eines proteaseresistenten menschlichen wachstumshormons
US7820422B2 (en) 2005-06-16 2010-10-26 Centre National De La Recherche Scientifique (Cnrs) Efficient production of oligosaccharides using metabolically engineered microorganisms
US8771991B2 (en) 2005-08-11 2014-07-08 National Research Council Of Canada SOAT polypeptide reaction mixture
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
JP2009526746A (ja) 2005-08-19 2009-07-23 セントカー・インコーポレーテツド タンパク質分解抵抗性の抗体調製物
JP2009511082A (ja) * 2005-10-17 2009-03-19 ヘルス リサーチ インコーポレイテッド 糖類のためのトランスフェラーゼに特異的な受容体並びにその入手及び使用方法
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP1999259B1 (de) 2006-03-03 2014-06-25 California Institute of Technology Ortsspezifische inkorporation von aminosäuren in moleküle
WO2007130453A2 (en) 2006-05-02 2007-11-15 Allozyne, Inc. Non-natural amino acid substituted polypeptides
AR078117A1 (es) 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
CA2665332A1 (en) 2006-10-03 2008-04-10 Centre National De La Recherche Scientifique (Cnrs) High yield production of sialic acid (neu5ac) by fermentation
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
CA2665480C (en) 2006-10-04 2019-11-12 Novo Nordisk A/S Glycerol linked pegylated sugars and glycopeptides
EP1911850A1 (de) * 2006-10-09 2008-04-16 Centre National De La Recherche Scientifique (Cnrs) Verfahren zur Herstellung von 6-thio-sialierten Glykoproteinen und Glycokonjugaten
CN101652377A (zh) * 2007-04-02 2010-02-17 泰拉科斯有限公司 苄基化糖苷衍生物及其用法
CN101796063B (zh) 2007-04-03 2017-03-22 拉蒂奥法姆有限责任公司 使用糖聚乙二醇化g‑csf的治疗方法
CA2682738A1 (en) 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
JP5702600B2 (ja) * 2007-07-03 2015-04-15 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド オリゴシアル酸誘導体、製造方法および免疫学的使用
WO2009045894A1 (en) 2007-09-28 2009-04-09 Centocor, Inc. Methods and structural conformations of antibody preparations with increased resistance to proteases
JP4826824B2 (ja) * 2007-12-03 2011-11-30 クミアイ化学工業株式会社 オリゴ糖
CN103497247A (zh) 2008-02-27 2014-01-08 诺沃—诺迪斯克有限公司 缀合的因子viii分子
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CA2793276A1 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
CA2768155C (en) 2009-06-16 2016-08-23 The University Of Bath Materials and methods relating to glycosylation
BR112012010252A2 (pt) 2009-10-29 2016-12-06 Janssen Biotech Inc variantes de glicosilação de anticorpo
US9921210B2 (en) 2010-04-07 2018-03-20 Momenta Pharmaceuticals, Inc. High mannose glycans
JP2014510045A (ja) 2011-02-08 2014-04-24 ハロザイム インコーポレイテッド ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症の治療のためのその使用
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
KR101828828B1 (ko) 2011-10-24 2018-03-29 할로자임, 아이엔씨 항-히알루로난 제제 치료를 위한 동반 진단 및 이의 사용 방법
BR112014016195A2 (pt) 2011-12-30 2020-10-27 Halozyme, Inc. variantes de polipeptídio ph20, formulações e usos das mesmas
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
TWI563092B (en) * 2012-08-20 2016-12-21 Academia Sinica Large scale enzymatic synthesis of oligosaccharides
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
SI2991683T1 (sl) 2013-05-02 2020-01-31 Glykos Finland Oy Konjugati glikoproteina ali glikana s toksično obremenitvijo
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
EP3240411A4 (de) * 2014-11-12 2019-02-20 Tumorend LLC Zusammensetzungen, verfahren und behandlungen zur hemmung der zelladhäsion und virusbindung und penetration
WO2018114879A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag Method for in vitro glycoengineering of antibodies
CN110100007B (zh) 2016-12-21 2024-05-28 豪夫迈·罗氏有限公司 用于体外糖工程化抗体的酶的再使用
CA3044920C (en) 2016-12-21 2022-06-28 Roberto Falkenstein In vitro glycoengineering of antibodies
CN106632531B (zh) * 2017-01-03 2019-02-22 河南科技学院 一种α-2,3羟乙酰唾液酸乳果糖的制备方法
EP3732186A1 (de) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunktionale inhibitoren von e-selektin und galectin-3
JP7547345B2 (ja) 2018-12-27 2024-09-09 グリコミメティクス， インコーポレイテッド ガレクチン－３阻害性ｃ－グリコシド
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
WO2020229968A1 (en) * 2019-05-10 2020-11-19 Alectos Therapeutics Inc. Non-lysosomal glucosylceramidase inhibitors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
SE451849B (sv) 1985-12-11 1987-11-02 Svenska Sockerfabriks Ab Sett att syntetisera glykosidiska bindningar samt anvendning av pa detta sett erhallna produkter
JPS62242691A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製法
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
DE3626915A1 (de) * 1986-08-08 1988-02-11 Hoechst Ag Verfahren zur enzymatischen synthese eines n-acetylneuraminsaeure-haltigen trisaccharids
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体
US5039523A (en) * 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
US5045469A (en) * 1988-10-27 1991-09-03 Mycogen Corporation Novel bacillus thuringiensis isolate denoted B. T. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
US5256788A (en) * 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
EP0481038B1 (de) * 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharidzusammensetzungen, Verfahren und Apparate zu deren Synthese
US5278299A (en) * 1991-03-18 1994-01-11 Scripps Clinic And Research Foundation Method and composition for synthesizing sialylated glycosyl compounds
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
ATE193551T1 (de) * 1991-03-18 2000-06-15 Scripps Research Inst Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen

Also Published As

Publication number Publication date
CA2106301A1 (en) 1992-09-19
AU668505B2 (en) 1996-05-09
CA2106301C (en) 1999-04-06
JP3476455B2 (ja) 2003-12-10
EP0576592A4 (en) 1996-01-24
US5759823A (en) 1998-06-02
DE69231127D1 (de) 2000-07-06
JPH06505638A (ja) 1994-06-30
US5593887A (en) 1997-01-14
WO1992016640A1 (en) 1992-10-01
EP0576592B1 (de) 2000-05-31
EP0576592A1 (de) 1994-01-05
AU1668092A (en) 1992-10-21
US6168934B1 (en) 2001-01-02

Similar Documents

Publication Publication Date Title
DE69231127D1 (de) Oligosaccharide als enzymsubstrate und -inhibitoren: verfahren und zusammensetzungen
NZ337701A (en) Process for processing sucrose into glucose and fructose
AU689043B2 (en) Steroid sulphatase inhibitors
ATE513916T1 (de) Deletionsmutante von neisseria glycosyltransferase für die oligosaccharidebiosynthese, und deren gene
NO844493L (no) Ultraren hyaluronsyre og fremgangsmaate til dens fremstilling
MXPA01007853A (es) Campylobacter glucosiltransferasas para la biosintesis de gangliosidos e imitaciones de gangliosidos.
HU9603376D0 (en) Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme
SE9301677L (sv) Syntesmetod
AU2829292A (en) Saccharin derivative proteolytic enzyme inhibitors
AU8208691A (en) Process for preparation of beta -lactams
AU7717598A (en) Control of immune responses by modulating activity of glycosyltransferase
ATE84313T1 (de) Substratunterstuetzte katalyse.
MY104354A (en) Non-peptidic renin inhibitors
AU2508695A (en) Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
Iwamori et al. Arthrobacter ureafaciens sialidase isoenzymes, L, M1 and M2, cleave fucosyl GM1
Urashima et al. Biosynthesis of marsupial milk oligosaccharides II: Characterization of a β6-N-acetylglucosaminyltransferase in lactating mammary glands of the tammar wallaby, Macropus eugenii
DE69619665D1 (de) Exopolysaccharid abbauendes enzym und verwendung davon
DE3167109D1 (en) Sucrose-mutase, immobilized sucrose-mutase and use of this immobilized sucrose-mutase for the production of isomaltulose(6-o-alpha-d-glucopyranosido-d fructose)
AU3063492A (en) Compositions and methods for template-dependent enzymatic synthesis of nucleic acid
AU2158200A (en) Novel inhibitors of farnesyl-protein transferase
CA2139506A1 (en) A Facile Enzymatic Synthesis of Galactosyl-Beta-1, 3 Glycals
MX9802377A (es) Proceso de reduccion microbiana estero selectiva.
AU3737097A (en) Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
AU571559B2 (en) Alpha-allenic-alpha amino acids
NO971196L (no) Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties